Best robotics ETFs to buy from India (2026): BOTZ vs ROBO vs IRBO — which one and why

In 2024, every major robotics ETF outperformed the S&P 500 — not because robot adoption accelerated, but because NVIDIA did. BOTZ, the largest robotics ETF, had NVIDIA as its top holding at ~23% of the portfolio. When NVIDIA returned 180% that year, BOTZ looked like a robotics success story. It was an AI chip story with a robotics label on it.

This matters for an Indian investor deciding whether to buy a robotics ETF or build a direct-stock portfolio using the humanoid robotics guide. The ETF route is simpler — one ticker, one trade, one line in Schedule FA. But most robotics ETFs are less robotics-specific than they appear, and they differ significantly from each other in what they actually hold.

This guide compares every meaningful robotics ETF available via LRS, looks inside the holdings, and tells you which one matches which thesis — humanoid robotics, industrial automation, AI-driven robotics, or the broad "robots in general" bet.

The four robotics ETFs worth comparing

ETF	AUM	TER	Top holding	NVDA weight	Listed
BOTZ	~$2.8B	0.68%	NVIDIA (~23%)	~23%	NASDAQ
ROBO	~$1.7B	0.95%	Equal-weight, ~80 names	~0%	NYSE Arca
IRBO	~$450M	0.47%	iRobot / diversified	~3%	NASDAQ
ARKQ	~$600M	0.75%	Tesla (~10%)	~0%	NYSE Arca

Each tracks a different index with a different philosophy. The NVIDIA weight is the most useful single number for quickly understanding what you're actually buying.

---

BOTZ — Global X Robotics & Artificial Intelligence ETF

AUM: ~$2.8B. TER: 0.68%. Tracks the Indxx Global Robotics & Artificial Intelligence Thematic Index. Approximately 45 holdings; concentrated in top names.

What's actually inside BOTZ (July 2026 approximate weights):

• NVIDIA: ~23%
• Intuitive Surgical: ~11%
• ABB Ltd: ~8%
• Keyence: ~7%
• Fanuc: ~6%
• SMC Corporation: ~5%
• Yaskawa Electric: ~4%
• Zebra Technologies: ~3%
• Cognex: ~3%
• iRobot: ~2%
• Remaining ~30 names: balance

The honest read: BOTZ is approximately 23% NVIDIA + 11% Intuitive Surgical (surgical robots — a completely separate business from industrial and humanoid) + ~40% Japanese and European industrial automation names (ABB, Keyence, Fanuc, SMC, Yaskawa) + a handful of US automation names.

If you're buying BOTZ for humanoid robotics exposure, you are getting: no Schaeffler (German XETRA-listed), no direct Tesla Optimus exposure, no pure humanoid play. You're getting a blend of AI chips (NVDA), surgical robots (ISRG), and 1980s-vintage Japanese industrial automation companies.

When BOTZ makes sense: You want the broadest possible automation exposure — industrial robots, surgical robots, AI compute for robots — in one US-listed ETF. You are comfortable with the NVIDIA concentration and accept that BOTZ's performance will be partly correlated to NVDA.

When BOTZ doesn't make sense: You want specifically humanoid robotics exposure. The Japanese industrial names (Fanuc, Yaskawa, SMC) are predominantly traditional articulated-arm industrial robots — the kind that weld car bodies and haven't changed fundamentally in 30 years. They are not humanoid plays.

Verdict — Add (as broad automation basket): The largest, most liquid robotics ETF. Concentration in NVDA and ISRG means it's not as diversified as it appears, but those are both high-quality businesses. Own if you want simplicity and the full automation spectrum. Don't own it thinking you're buying a humanoid-specific fund.

---

ROBO — ROBO Global Robotics and Automation Index ETF

AUM: ~$1.7B. TER: 0.95%. Tracks the ROBO Global Robotics and Automation Index. ~80 equal-weighted holdings across robotics, automation, and AI for robotics. The equal-weight construction is the key differentiator from BOTZ.

What's actually inside ROBO (July 2026 approximate weights):

• Equal-weighted at roughly 1.1–1.5% per name across ~80 companies
• Includes: Intuitive Surgical, Cognex, Zebra Technologies, Teradyne, Fanuc, Keyence, SMC, Yaskawa, Harmonic Drive Systems, Nabtesco, iRobot, Omron, Sick AG, Hexagon AB, Rockwell Automation, Emerson Electric...

NVIDIA weight: approximately 0%. ROBO's index methodology focuses on companies that derive significant revenue from robotics and automation — NVIDIA's revenue is predominantly AI chips for data centers, so ROBO's index doesn't classify it as a robotics company. This is either a bug or a feature depending on your view.

The honest read: ROBO is a more diversified, equal-weight basket that genuinely tracks the robotics supply chain. Harmonic Drive Systems and Nabtesco (precision gears — the same actuator components that represent 56% of the humanoid BOM) appear in ROBO but not prominently in BOTZ. Hexagon AB (the AEON humanoid — the most production-real humanoid story as of mid-2026) is in ROBO. The equal weighting means no single NVIDIA-sized distortion.

The higher TER (0.95% vs 0.68% for BOTZ) is a real cost drag over long holding periods.

When ROBO makes sense: You want genuine robotics supply chain exposure without NVIDIA concentration. You want Harmonic Drive, Nabtesco, Hexagon, and the actual actuator and precision component makers in your portfolio. You're willing to pay the extra fees for the index construction quality.

Verdict — Core buy for humanoid/robotics thesis: ROBO is a better match for the investor who read the humanoid robotics guide and wants ETF-level exposure to the BOM layers. More expensive, but the holdings are more honest about what robotics actually is. Own alongside a direct NVDA position if you want the AI chip layer too.

---

IRBO — iShares Robotics and Artificial Intelligence Multisector ETF

AUM: ~$450M. TER: 0.47%. Tracks the NYSE FactSet Global Robotics and Artificial Intelligence Index. ~100+ holdings; modified equal-weight within tiers.

What's actually inside IRBO:

• Roughly equal-weight across ~100 names
• Broader mandate than BOTZ or ROBO — includes more software and AI names alongside hardware robotics
• Names like Palantir, Trimble, Zebra Technologies, Teradyne, Rockwell Automation, plus some AI software names
• NVIDIA weight: ~3% (included but not at BOTZ concentration)

The honest read: IRBO has the lowest TER (0.47%) and the broadest mandate. The breadth cuts both ways — you get more diversification but less robotics specificity. The inclusion of AI software and analytics names (Palantir, Trimble) alongside robot makers means IRBO is the most "AI + automation" basket rather than a pure robotics fund.

IRBO's AUM is significantly smaller than BOTZ or ROBO — daily liquidity is lower, and the bid-ask spread may be wider on thin trading days. For Indian retail investors buying via LRS in smaller ticket sizes (₹5–25 lakh), this shouldn't materially matter, but it's worth noting.

Verdict — Add (for cost-sensitive investors): The cheapest of the three at 0.47% TER. If you want broad automation exposure and cost matters most, IRBO is the answer. If you want robotics specificity, ROBO is better despite the higher fee. If you want liquidity and simplicity, BOTZ.

---

ARKQ — ARK Autonomous Technology & Robotics ETF

AUM: ~$600M. TER: 0.75%. Actively managed by ARK Invest (Cathie Wood). Not index-tracking — ARK's analysts make active allocation decisions based on their 5-year price targets and conviction scores.

What's actually inside ARKQ (July 2026 approximate weights):

• Tesla: ~10%
• Archer Aviation: ~8%
• Joby Aviation: ~7%
• Kratos Defense: ~6%
• UiPath: ~5%
• Trimble: ~5%
• Teradyne: ~5%
• Iridium: ~4%
• Remaining names: balance

The honest read: ARKQ is not a robotics ETF in the traditional sense — it's Cathie Wood's high-conviction disruptive technology fund with a "autonomous technology and robotics" label. The top holdings include Tesla (electric vehicle + Optimus humanoid + FSD — a business with $90B revenue), Archer Aviation and Joby (eVTOL — covered in the drone guide), and UiPath (software automation — RPA, not physical robots).

ARK's active management has been volatile — ARKQ significantly underperformed from 2021–2023 and recovered partially in 2024. Active management means your performance depends on whether ARK's research and timing is better than the market's.

When ARKQ makes sense: You believe in ARK's disruptive technology framework, you want Tesla and eVTOL in a "robotics" wrapper, and you're comfortable with active management risk. Some Indian investors specifically want Cathie Wood's conviction plays in a single ETF.

When ARKQ doesn't make sense: You want the actual robotics supply chain (actuators, precision components, industrial robots). ARKQ barely touches Harmonic Drive, Fanuc, Yaskawa, or any of the BOM-layer companies covered in the humanoid robotics guide.

Verdict — Skip (for most investors): ARK's track record is genuinely mixed. ARKQ is less "robotics ETF" and more "Cathie Wood high-conviction tech." If you want Tesla, buy Tesla. If you want Joby, buy Joby. Don't pay 0.75% active management fee for a bundle you can construct yourself.

---

The overlap problem

BOTZ, ROBO, and IRBO share many holdings — Intuitive Surgical, Cognex, Keyence, Fanuc, and Zebra Technologies appear in all three. Owning two robotics ETFs is not twice the diversification; it's often just higher total fees for the same underlying exposure.

Overlap matrix (approximate):

Pair	Holdings overlap
BOTZ + ROBO	~40% of names overlap
BOTZ + IRBO	~35% of names overlap
ROBO + IRBO	~45% of names overlap

If you're going to own one, own the one that best matches your thesis (ROBO for humanoid/BOM-layer, BOTZ for simplicity and liquidity, IRBO for cost). Don't own two of these three — it dilutes the thesis without adding meaningful diversification.

---

Comparing ETFs vs direct stocks

The humanoid robotics guide covered 30 individual names. Here's when to use each approach:

Situation	Use ETF (ROBO/BOTZ)	Use direct stocks
First ₹5–10 lakh in robotics	✅	—
Want XETRA-listed names (Schaeffler, Harmonic Drive as direct)	—	✅
Want to overweight a specific layer (actuators)	—	✅
Don't want to monitor individual positions	✅	—
Want to avoid NVIDIA concentration in robotics allocation	✅ ROBO	—
Want maximum liquidity (quick exit)	✅ BOTZ	—

The cleanest approach for most Indian investors: ROBO as the core ETF for the broad robotics basket, plus 2–3 direct stocks for the highest-conviction specific names (e.g., NVDA directly for the compute layer, Schaeffler via IBKR for the actuator layer).

---

Three model portfolios

Portfolio 1 — ETF-only robotics (₹3–10 lakh, simple)

Name	Allocation	Why
ROBO	60%	Best equal-weight supply chain exposure
BOTZ	40%	Liquidity + Intuitive Surgical + NVDA complement

Avoid owning all three ETFs. ROBO + BOTZ covers the full spectrum with limited overlap.

Portfolio 2 — ETF core + direct satellites (₹10–25 lakh)

Name	Allocation	Why
ROBO	40%	Broad equal-weight basket including actuator names
NVDA	25%	AI compute layer, direct (not via BOTZ dilution)
QCOM	15%	Named humanoid customer (Dragonwing), cheap valuation
BOTZ	20%	Liquidity + Intuitive Surgical + industrial Japan

Portfolio 3 — Full BOM-layer construction (₹25 lakh+ via IBKR)

Skip the ETFs; build the BOM directly from the humanoid robotics guide. IBKR India provides access to XETRA (Schaeffler) and TSE (Harmonic Drive Systems) listings that Vested and INDmoney cannot route.

Layer	Name	Allocation
Compute	NVDA	20%
Compute	QCOM	10%
Actuators	Schaeffler (XETRA: SHA)	15%
Actuators	Harmonic Drive Systems (TSE: 6324)	10%
Sensors/Vision	Hexagon AB (OMX: HEXA B)	10%
Industrial	ABB Ltd	10%
Industrial	Keyence (TSE: 6861)	10%
Software	UiPath (PATH)	5%
Surgical	ISRG	10%

Note: TSE and XETRA listings require IBKR India (or equivalent multi-currency broker). Vested and INDmoney route primarily to US exchanges. If you're limited to US-listed names, substitute with the ADRs where available or revert to ROBO for the non-US names.

---

Indian investor execution guide

LRS access

BOTZ, ROBO, IRBO, and ARKQ are all US-listed ETFs accessible via LRS on:

• Vested — DriveWealth; all four ETFs accessible
• INDmoney — DriveWealth / Alpaca; ETF access confirmed
• Interactive Brokers India — best for IRBO (lower liquidity) and for XETRA/TSE direct names in Portfolio 3
• Rovia — Alpaca Securities

Tax treatment

ETF units held ≥ 24 months: LTCG 12.5% flat (Section 112). No indexation benefit for foreign ETFs. ETF units held < 24 months: STCG at slab rate.

Robotics ETFs (BOTZ, ROBO, IRBO, ARKQ) pay small annual dividends (typically <0.5% yield). US withholding tax applies at 15% under DTAA; file Form W-8BEN. Residual Indian dividend tax at slab. File Form 44 for foreign tax credit. Given the tiny yield, the dividend tax complexity is minimal — but Schedule FA disclosure is required.

Schedule FA: All ETF holdings on March 31 must be disclosed. For ETFs, report the number of units, purchase cost in INR, peak NAV during the year converted to INR, and closing NAV.

TCS

20% TCS on LRS remittances above ₹7 lakh per financial year. TCS is a credit against your tax liability — not a permanent cost. Plan timing of remittances to manage cash flow.

---

The one-line version

If you want robotics exposure in a single ETF, buy ROBO — it tracks the actual supply chain (including actuator and precision component makers) without NVIDIA concentration distorting the allocation. If you want simplicity and maximum liquidity, buy BOTZ. If you want cost efficiency, buy IRBO. Don't own two of these three. And if you've already read the humanoid robotics guide and have conviction on specific BOM layers, you're better served owning those names directly than paying 0.68–0.95% TER for the ETF wrapper.